BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37173713)

  • 1. Impacts of ovarian preservation on the prognosis of neuroendocrine cervical carcinoma: a retrospective analysis based on machine learning.
    Xiang X; Zhang Y; Hua K; Ding J
    World J Surg Oncol; 2023 May; 21(1):146. PubMed ID: 37173713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Factors and Impact of Minimally Invasive Surgery in Early-stage Neuroendocrine Carcinoma of the Cervix.
    Kim JH; Shim SH; Nam SH; Lee SW; Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT
    J Minim Invasive Gynecol; 2020; 27(7):1558-1565. PubMed ID: 32084588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of ovarian preservation in women with stage I and II cervical adenocarcinoma: a retrospective study and meta-analysis.
    Chen J; Wang R; Zhang B; Lin X; Wei J; Jia Y; Yin Y; Ye S; Zhu T; Chen G; Yuan Y; Lu W; Li K
    Am J Obstet Gynecol; 2016 Oct; 215(4):460.e1-460.e13. PubMed ID: 27133009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of recurrence and survival in neuroendocrine cervical cancer.
    Stecklein SR; Jhingran A; Burzawa J; Ramalingam P; Klopp AH; Eifel PJ; Frumovitz M
    Gynecol Oncol; 2016 Dec; 143(3):552-557. PubMed ID: 27645621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population.
    Zhang X; Lv Z; Lou H
    BMC Cancer; 2019 Jan; 19(1):22. PubMed ID: 30616631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should ovaries be removed or not in early-stage cervical adenocarcinoma: a multicenter retrospective study of 105 patients.
    Hu J; Jiao X; Yang Z; Cui H; Guo H; Wu Y; Zhu L
    J Obstet Gynaecol; 2017 Nov; 37(8):1065-1069. PubMed ID: 28631536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring a Better Adjuvant Treatment for Surgically Treated High-Grade Neuroendocrine Carcinoma of the Cervix.
    Wang R; Xiao Y; Ma L; Wu Z; Xia H
    Gynecol Obstet Invest; 2022; 87(6):398-405. PubMed ID: 36273460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the initial site of metastases on post-recurrence survival for neuroendocrine cervical cancer.
    Pan B; Wan T; Jiang Y; Zheng X; Liu P; Xiang H; Zheng M
    BMC Cancer; 2022 Jun; 22(1):655. PubMed ID: 35698184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Prognostic Impacts of Ovarian Preservation during Radical Hysterectomy for Early-Stage Adenocarcinoma and Adenosquamous Cervical Cancer.
    Theplib A; Hanprasertpong J; Leetanaporn K
    Biomed Res Int; 2020; 2020():5791381. PubMed ID: 33274215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distant organ metastasis patterns and prognosis of neuroendocrine cervical carcinoma: a population-based retrospective study.
    Li Q; Yu J; Yi H; Lan Q
    Front Endocrinol (Lausanne); 2022; 13():924414. PubMed ID: 36051393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis.
    Hu T; Wu L; Xing H; Yang R; Li X; Huang K; Jia Y; Zhang Q; Chen Z; Wang S; Liu D; Han X; Lin Z; Qu P; Cai H; Song X; Tian X; Wang H; Wang S; Xie X; Li S; Ma D
    Ann Surg Oncol; 2013 Mar; 20(3):881-90. PubMed ID: 23054110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical treatment for neuroendocrine carcinoma of the uterine cervix.
    Kasamatsu T; Sasajima Y; Onda T; Sawada M; Kato T; Tanikawa M
    Int J Gynaecol Obstet; 2007 Dec; 99(3):225-8. PubMed ID: 17897648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does ovarian preservation have an effect on recurrence of early stage low-grade endometrial stromal sarcoma?
    Karataşlı V; Çakır İ; Can B; Erkılınç S; Karadeniz T; Kuru O; Gökçü M; Sancı M
    J Obstet Gynaecol; 2021 Jul; 41(5):797-802. PubMed ID: 33063586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
    Feng M; Zou J; Zhang Y; Sun L
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of radiotherapy in neuroendocrine cervical cancer: SEER-based study.
    Dong M; Gu X; Ma T; Mi Y; Shi Y; Fan R
    Sci Prog; 2021; 104(2):368504211009336. PubMed ID: 33848229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?
    Nasioudis D; Chapman-Davis E; Frey MK; Witkin SS; Holcomb K
    J Gynecol Oncol; 2017 Nov; 28(6):e71. PubMed ID: 28758377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Factors of Surgically Treated Early-Stage Small Cell Neuroendocrine Carcinoma of the Cervix.
    Yuan L; Jiang H; Lu Y; Guo SW; Liu X
    Int J Gynecol Cancer; 2015 Sep; 25(7):1315-21. PubMed ID: 26186071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is Ovarian Preservation Feasible in Early-Stage Adenocarcinoma of the Cervix?
    Lu H; Li J; Wang L; Zhou H; Liu Y; Wang D; Lin Z
    Med Sci Monit; 2016 Feb; 22():408-14. PubMed ID: 26852916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.